ERYC SPRINKLES Drug Patent Profile
✉ Email this page to a colleague
When do Eryc Sprinkles patents expire, and what generic alternatives are available?
Eryc Sprinkles is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in ERYC SPRINKLES is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eryc Sprinkles
A generic version of ERYC SPRINKLES was approved as erythromycin by TORRENT on July 6th, 2020.
Summary for ERYC SPRINKLES
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 10 |
Patent Applications: | 5,687 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ERYC SPRINKLES at DailyMed |
Recent Clinical Trials for ERYC SPRINKLES
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vanderbilt University Medical Center | Phase 2 |
St. Jude Children's Research Hospital | Phase 2 |
Emas Pharma Ltd. | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for ERYC SPRINKLES
US Patents and Regulatory Information for ERYC SPRINKLES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | ERYC SPRINKLES | erythromycin | CAPSULE, DELAYED REL PELLETS;ORAL | 050593-001 | Jul 22, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |